Literature DB >> 16182261

Intermittent dosing prolongs tolerance to the antinociceptive effect of morphine microinjection into the periaqueductal gray.

Michael M Morgan1, Bradley W Tierney, Susan L Ingram.   

Abstract

Tolerance to the antinociceptive effect of microinjecting morphine into the ventrolateral periaqueductal gray (vPAG) develops with repeated administration. The objective of the present experiment was to determine whether the magnitude and duration of tolerance differ depending on the interval between injections. Rats were injected with morphine or saline into the vPAG either once daily for 4 days or twice daily for 2 days. All rats were injected with morphine into the vPAG for the fifth injection to determine whether tolerance had developed. Morphine microinjection produced tolerance in both morphine-pretreated groups regardless of inter-dose interval. One and two weeks later, microinjection of morphine produced an increase in hot plate latency in all groups except rats pretreated with daily morphine microinjections. That is, tolerance was evident 2 weeks following the induction of tolerance produced by daily, but not twice daily injections of morphine. Although a long inter-dose interval has been shown to prolong the duration of tolerance after systemic morphine administration, this is the first report showing a similar effect with direct administration of morphine into the brain. Given that associative learning underlies prolonged tolerance with systemic morphine administration, the present data suggest that associative mechanisms of tolerance are also engaged when morphine administration is restricted to the PAG.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16182261     DOI: 10.1016/j.brainres.2005.08.024

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  Extracellular signal-regulated kinase 1/2 activation counteracts morphine tolerance in the periaqueductal gray of the rat.

Authors:  Tara A Macey; Erin N Bobeck; Deborah M Hegarty; Sue A Aicher; Susan L Ingram; Michael M Morgan
Journal:  J Pharmacol Exp Ther       Date:  2009-08-14       Impact factor: 4.030

2.  Differential development of antinociceptive tolerance to morphine and fentanyl is not linked to efficacy in the ventrolateral periaqueductal gray of the rat.

Authors:  Erin N Bobeck; Rachel A Haseman; Dana Hong; Susan L Ingram; Michael M Morgan
Journal:  J Pain       Date:  2012-07-03       Impact factor: 5.820

3.  The periaqueductal gray contributes to bidirectional enhancement of antinociception between morphine and cannabinoids.

Authors:  Adrianne R Wilson-Poe; Edvinas Pocius; Melissa Herschbach; Michael M Morgan
Journal:  Pharmacol Biochem Behav       Date:  2012-10-10       Impact factor: 3.533

4.  Transcutaneous electrical nerve stimulation at both high and low frequencies activates ventrolateral periaqueductal grey to decrease mechanical hyperalgesia in arthritic rats.

Authors:  J M DeSantana; L F S Da Silva; M A De Resende; K A Sluka
Journal:  Neuroscience       Date:  2009-07-02       Impact factor: 3.590

5.  Evidence for an important role of protein phosphatases in the mechanism of morphine tolerance.

Authors:  Bichoy H Gabra; Chris P Bailey; Eamonn Kelly; Amanda V Sanders; Graeme Henderson; Forrest L Smith; William L Dewey
Journal:  Brain Res       Date:  2007-05-21       Impact factor: 3.252

6.  Analgesic tolerance to microinjection of the micro-opioid agonist DAMGO into the ventrolateral periaqueductal gray.

Authors:  Paul J Meyer; Erin N Fossum; Susan L Ingram; Michael M Morgan
Journal:  Neuropharmacology       Date:  2007-03-12       Impact factor: 5.250

7.  Chronic inflammatory pain prevents tolerance to the antinociceptive effect of morphine microinjected into the ventrolateral periaqueductal gray of the rat.

Authors:  Melissa L Mehalick; Susan L Ingram; Sue A Aicher; Michael M Morgan
Journal:  J Pain       Date:  2013-10-22       Impact factor: 5.820

8.  Tolerance to repeated morphine administration is associated with increased potency of opioid agonists.

Authors:  Susan L Ingram; Tara A Macey; Erin N Fossum; Michael M Morgan
Journal:  Neuropsychopharmacology       Date:  2007-11-28       Impact factor: 7.853

9.  Repeated cannabinoid injections into the rat periaqueductal gray enhance subsequent morphine antinociception.

Authors:  Adrianne R Wilson; Lauren Maher; Michael M Morgan
Journal:  Neuropharmacology       Date:  2008-08-05       Impact factor: 5.250

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.